Dermatologic manifestations of the antiphospholipid syndrome;Manifestations dermatologiques du syndrome des antiphospholipides

Revue de Medecine Interne

Volumn 33, Issue 4, 2012, Pages 200-205

  Frances C ^a   Barete, S ^a   Soria, A ^a  

^a HÔPITAL TENON   (France)

Author keywords

Antiphospholipid syndrome; Livedo; Necrosis

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ANETODERMA; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; HUMAN; LIVEDO RETICULARIS; RECURRENT DISEASE; SHORT SURVEY; SKIN BIOPSY; SKIN DEFECT; SKIN MANIFESTATION; SKIN NECROSIS; SKIN ULCER; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; VEIN THROMBOSIS;

ANETODERMA; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HEPARIN; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; LIVEDO RETICULARIS; PLASMA EXCHANGE; SKIN DISEASES; SKIN DISEASES, VASCULAR; TREATMENT OUTCOME; VASCULITIS;

EID: 84858754201     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2011.10.003     Document Type: Short Survey

References (40)

1. Hughes G.R. The Prosser-White oration 1983. Connective tissue disease and the skin. Clin Exp Dermatol 1984, 9:535-544.
2. Cervera R., Piette J.C., Font J., Khamashta M.A., Shoenfeld Y., Camps M.T., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002, 46:1019-1027.
3. Frances C., Niang S., Laffitte E., Pelletier F., Costedoat N., Piette J.C. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum 2005, 52:1785-1793.
4. Garcia-Carrasco M., Galarza C., Gomez-Ponce M., Cervera R., Rojas-Rodriguez J., Espinosa G., et al. Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients. Lupus 2007, 16:366-373.
5. Uthman I.W., Khamashta M.A. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol 2006, 33:2379-2382.
6. Toubi E., Krause I., Fraser A., Lev S., Stojanovich L., Rovensky J., et al. Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome. Clin Exp Rheumatol 2005, 23:499-504.
7. Avcin T., Cimaz R., Silverman E.D., Cervera R., Gattorno M., Garay S., et al. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics 2008, 122:e1100-e1107.
8. Frances C., Papo T., Wechsler B., Laporte J.L., Biousse V., Piette J.C. Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients. Medicine (Baltimore) 1999, 78:209-219.
9. Weinstein S., Piette W. Cutaneous manifestations of antiphospholipid antibody syndrome. Hematol Oncol Clin North Am 2008, 22:67-77. [vi].
10. Bowie E.J., Thompson J.H., Pascuzzi C.A., Owen C.A. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963, 62:416-430.
11. Alarcon-Segovia D., Deleze M., Oria C.V., Sanchez-Guerrero J., Gomez-Pacheco L., Cabiedes J., et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989, 68:353-365.
12. Acland K.M., Darvay A., Wakelin S.H., Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?. Br J Dermatol 1999, 140:131-135.
13. Tran M.D., Becherel P.A., Cordel N., Piette J.C., Frances C. Atrophie blanche « idiopathique ». Ann Dermatol Venereol 2001, 128:1003-1007.
14. Chacek S., MacGregor-Gooch J., Halabe-Cherem J., Nellen-Hummel H., Quinones-Galvan A. Pyoderma gangrenosum and extensive caval thrombosis associated with the antiphospholipid syndrome - a case report. Angiology 1998, 49:157-160.
15. Schmid M.H., Hary C., Marstaller B., Konz B., Wendtner C.M. Pyoderma gangrenosum associated with the secondary antiphospholipid syndrome. Eur J Dermatol 1998, 8:45-47.
16. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
17. Bessis D., Sotto A., Viard J.P., Berard M., Ciurana A.J., Boffa M.C. Trousseau's syndrome with nonbacterial thrombotic endocarditis: pathogenic role of antiphospholipid syndrome. Am J Med 1995, 98:511-513.
18. Lipsker D., Kara F. Images in clinical medicine. Retiform purpura. N Engl J Med 2008, 358:e1.
19. Creamer D., Black M.M., Calonje E. Reactive angioendotheliomatosis in association with the antiphospholipid syndrome. J Am Acad Dermatol 2000, 42:903-906.
20. Hodak E., David M. Primary anetoderma and antiphospholipid antibodies--review of the literature. Clin Rev Allergy Immunol 2007, 32:162-166.
21. Romani J., Perez F., Llobet M., Planaguma M., Pujol R.M. Anetoderma associated with antiphospholipid antibodies: case report and review of the literature. J Eur Acad Dermatol Venereol 2001, 15:175-178.
22. Sparsa A., Piette J.C., Wechsler B., Amoura Z., Frances C. Anetoderma and its prothrombotic abnormalities. J Am Acad Dermatol 2003, 49:1008-1012.
23. Stephansson E.A., Niemi K.M. Antiphospholipid antibodies and anetoderma: are they associated?. Dermatology 1995, 191:204-209.
24. Moulis G, Delavigne K, Huguet F, Fortenfant F, Beyne-Rauzy O, Adoue D. Profil des anticorps antiphospholipides et risque de thrombose : étude comparative entre thrombopénie immunologique chronique et syndrome des antiphospholipides primaire. Rev Med Interne, 2011 Aug 22. [Epub ahead of print] French. doi:10.1016/j.revmed.2011.07.014.
25. Weinstein C., Miller M.H., Axtens R., Buchanan R., Littlejohn G.O. Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 1987, 123:596-600.
26. Nochy D., Daugas E., Huong D.L., Piette J.C., Hill G. Kidney involvement in the antiphospholipid syndrome. J Autoimmun 2000, 15:127-132.
27. Krause I., Leibovici L., Blank M., Shoenfeld Y. Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis. Lupus 2007, 16:176-180.
28. Frances C., Piette J.C., Saada V., Papo T., Wechsler B., Chosidow O., et al. Multiple subungual splinter hemorrhages in the antiphospholipid syndrome: a report of five cases and review of the literature. Lupus 1994, 3:123-128.
29. Asherson R.A. The catastrophic antiphospholipid syndrome. J Rheumatol 1992, 19:508-512.
30. Asherson R.A., Cervera R., Piette J.C., Font J., Lie J.T., Burcoglu A., et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998, 77:195-207.
31. Stojanovich L., Marisavljevic D., Rovensky J., Djokovich A., Kozakova D., Milinic N. Clinical and laboratory features of the catastrophic antiphospholipid syndrome. Clin Rev Allergy Immunol 2009, 36:74-79.
32. Toubi E., Shoenfeld Y. Livedo reticularis as a criterion for antiphospholipid syndrome. Clin Rev Allergy Immunol 2007, 32:138-144.
33. Ruiz-Irastorza G., Crowther M., Branch W., Khamashta M.A. Antiphospholipid syndrome. Lancet 2010, 376:1498-1509.
34. Erkan D. Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome. Autoimmun Rev 2006, 6:98-103.
35. Frances C., Barete S. Difficult management of livedoid vasculopathy. Arch Dermatol 2004, 140:1011.
36. Gertner E. Treatment with sildenafil for the healing of refractory skin ulcerations in the antiphospholipid syndrome. Lupus 2003, 12:133-135.
37. Cervera R., Khamashta M.A., Shoenfeld Y., Camps M.T., Jacobsen S., Kiss E., et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 2009, 68:1428-1432.
38. Del Castillo L.F., Soria C., Schoendorff C., Garcia Garcia C., Diez-Caballero N., Rodriguez Alen A., et al. Widespread cutaneous necrosis and antiphospholipid antibodies: two episodes related to surgical manipulation and urinary tract infection. J Am Acad Dermatol 1997, 36:872-875.
39. Rand J.H., Wu X.X., Quinn A.S., Chen P.P., Hathcock J.J., Taatjes D.J. Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers. Blood 2008, 112:1687-1695.
40. Szymezak J., Ankri A., Fischer A.M., Darnige L. Hydroxychloroquine: une nouvelle approche therapeutique des manifestations thrombotiques du syndrome des antiphospholipides. Rev Med Interne 2010, 31:854-857.